Citation 3749

DAT,NT: LEE,JH: LEE,K: HONG,YS: KIM,YH: LEE,JJ:. (2008). PHENOLIC CONSTITUENTS OF AMORPHA FRUTICOSA THAT INHIBIT NF-KB ACTIVATION AND RELATED GENE EXPRESSION. 71(10)

Citation Details

Title	PHENOLIC CONSTITUENTS OF AMORPHA FRUTICOSA THAT INHIBIT NF-KB ACTIVATION AND RELATED GENE EXPRESSION
Authors	DAT,NT: LEE,JH: LEE,K: HONG,YS: KIM,YH: LEE,JJ:
Year	2008
Volume	71
Issue	10

Summary

Year: 2008

Journal: Unknown

Organisms and Their Experiments (2)

Amorpha fruticosa (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	TEPHROSIN	None
4	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN	STRONG ACTIVITY
5	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN	ACTIVE
6	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	TEPHROSIN,11-HYDROXY:	None
7	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN,11-HYDROXY:	STRONG ACTIVITY
8	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN,11-HYDROXY:	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	DEGUELIN	None
10	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	STRONG ACTIVITY
11	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FOR	AMORPHISPIRONONE	None
13	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE	ACTIVE
14	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE	ACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	AMORPHISPIRONONE,1-AR-6-AS-12-AR-11-HYDROXY:	None
16	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE,1-AR-6-AS-12-AR-11-HYDROXY:	ACTIVE
17	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE,1-AR-6-AS-12-AR-11-HYDROXY:	ACTIVE
18	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	AMORFRUTIN A	None
19	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORFRUTIN A	STRONG ACTIVITY
20	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORFRUTIN A	ACTIVE
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BIBENZYL,3-CARBOXYL-5-HYDROXY-3-METHOXY-4-PRENYL:	None
22	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,3-CARBOXYL-5-HYDROXY-3-METHOXY-4-PRENYL:	ACTIVE
23	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,3-CARBOXYL-5-HYDROXY-3-METHOXY-4-PRENYL:	ACTIVE
24	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BIBENZYL,2-CARBOXY-4-GERANYL-5-HYDROXY-3-METHOXY:	None
25	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,2-CARBOXY-4-GERANYL-5-HYDROXY-3-METHOXY:	ACTIVE
26	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,2-CARBOXY-4-GERANYL-5-HYDROXY-3-METHOXY:	ACTIVE
27	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BIBENZYL,2-CARBOXY-3-4-DIHYDROXY-4-GENANYL:	None
28	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,2-CARBOXY-3-4-DIHYDROXY-4-GENANYL:	ACTIVE

Amorpha fruticosa (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	TEPHROSIN	None
4	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN	STRONG ACTIVITY
5	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN	ACTIVE
6	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	TEPHROSIN,11-HYDROXY:	None
7	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN,11-HYDROXY:	STRONG ACTIVITY
8	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN,11-HYDROXY:	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	DEGUELIN	None
10	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	STRONG ACTIVITY
11	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FOR	AMORPHISPIRONONE	None
13	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE	ACTIVE
14	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE	ACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	AMORPHISPIRONONE,1-AR-6-AS-12-AR-11-HYDROXY:	None
16	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE,1-AR-6-AS-12-AR-11-HYDROXY:	ACTIVE
17	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHISPIRONONE,1-AR-6-AS-12-AR-11-HYDROXY:	ACTIVE
18	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	AMORFRUTIN A	None
19	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORFRUTIN A	STRONG ACTIVITY
20	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORFRUTIN A	ACTIVE
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BIBENZYL,3-CARBOXYL-5-HYDROXY-3-METHOXY-4-PRENYL:	None
22	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,3-CARBOXYL-5-HYDROXY-3-METHOXY-4-PRENYL:	ACTIVE
23	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,3-CARBOXYL-5-HYDROXY-3-METHOXY-4-PRENYL:	ACTIVE
24	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BIBENZYL,2-CARBOXY-4-GERANYL-5-HYDROXY-3-METHOXY:	None
25	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,2-CARBOXY-4-GERANYL-5-HYDROXY-3-METHOXY:	ACTIVE
26	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,2-CARBOXY-4-GERANYL-5-HYDROXY-3-METHOXY:	ACTIVE
27	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BIBENZYL,2-CARBOXY-3-4-DIHYDROXY-4-GENANYL:	None
28	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIBENZYL,2-CARBOXY-3-4-DIHYDROXY-4-GENANYL:	ACTIVE
29	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	AMORPHASTILBOL	None
30	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHASTILBOL	STRONG ACTIVITY
31	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMORPHASTILBOL	STRONG ACTIVITY
32	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	XANTHOANGELOL	None
33	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOANGELOL	ACTIVE
34	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOANGELOL	ACTIVE
35	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	LIQUIRITIGENIN,ISO: 2'-METHOXY:	None
36	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO: 2'-METHOXY:	INACTIVE
37	NUCLEAR FACTOR KAPPA-BETA BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO: 2'-METHOXY:	INACTIVE

Citation 3749

Citation Details

Summary

Organisms and Their Experiments (2)

Amorpha fruticosa (FABACEAE)

Amorpha fruticosa (FABACEAE)

Show SPARQL Queries (1)

Query 1